ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.636,96
1,07%
S&P 500
5.447,87
-0,31%
US Dollar vs BRL
5,3909
0,00%
Bitcoin
61.137,52
1,44%
Brent Oil
85,195
-0,09%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Akers Biosciences Inc (AKER)

  7. Akers Biosciences Inc (AKER) Notícias

AKER

Akers Biosciences (AKER)

Akers Biosciences Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:AKER
DataHoraFonteTítuloCódigoCompanhia
20/06/202318:01Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:AKERAkers Biosciences Inc
09/06/202319:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AKERAkers Biosciences Inc
09/06/202317:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AKERAkers Biosciences Inc
31/03/202318:03Edgar (US Regulatory)Annual Report (10-k)NASDAQ:AKERAkers Biosciences Inc
13/03/202317:30Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:AKERAkers Biosciences Inc
23/02/202311:01Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:AKERAkers Biosciences Inc
14/02/202309:41Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AKERAkers Biosciences Inc
10/11/202219:03Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AKERAkers Biosciences Inc
26/10/202218:20Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:AKERAkers Biosciences Inc
08/09/202217:23Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:AKERAkers Biosciences Inc
30/08/202209:00Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:AKERAkers Biosciences Inc
05/07/202217:41Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:AKERAkers Biosciences Inc
15/11/202118:54Edgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:AKERAkers Biosciences Inc
02/07/202117:01Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:AKERAkers Biosciences Inc
18/05/202107:07Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:AKERAkers Biosciences Inc
12/05/202107:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:AKERAkers Biosciences Inc
11/05/202117:28Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:AKERAkers Biosciences Inc
29/04/202117:10GlobeNewswire Inc.Contango Announces the Appointment of Two New DirectorsNASDAQ:AKERAkers Biosciences Inc
28/04/202118:26Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:AKERAkers Biosciences Inc
21/04/202117:49Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:AKERAkers Biosciences Inc
16/04/202113:30Business WireAkers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of MergerNASDAQ:AKERAkers Biosciences Inc
13/04/202110:00Business WireAkers’ Proposed Merger Partner MyMD Pharmaceuticals Announces Plans to Initiate COVID-19 Inflammatory Depression TrialNASDAQ:AKERAkers Biosciences Inc
12/04/202110:00Business WireAkers’ Proposed Merger Partner MyMD Pharmaceuticals Announces Formation of Scientific Advisory BoardNASDAQ:AKERAkers Biosciences Inc
25/03/202120:37Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:AKERAkers Biosciences Inc
22/03/202118:22Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:AKERAkers Biosciences Inc
22/03/202109:00Business WireAkers Biosciences Announces Shareholder Meeting to Vote on Business Combination with MyMD PharmaceuticalsNASDAQ:AKERAkers Biosciences Inc
19/03/202115:03Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:AKERAkers Biosciences Inc
23/02/202111:00Business WireMyMD Pharmaceuticals Announces New Data on Its Lead Compound MYMD-1 from a Phenotypic Study Performed by Eurofins DiscoveryNASDAQ:AKERAkers Biosciences Inc
18/02/202116:23Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:AKERAkers Biosciences Inc
18/02/202111:00Business WireStudy Identifies Effects of Temperature Changes on SARS-CoV-2 TransmissionNASDAQ:AKERAkers Biosciences Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:AKER

Seu Histórico Recente

BOV
NFLX34
Netflix
LSE
82TL
Arran 2.a2b56a
COIN
LRCETH
LoopringCoin V2
TG
ME9
Mediobanca Banca di Cred...
NASDAQ
PSNYW
Polestar Automotive Hold...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados